Evolent Health, Inc. financial data

Symbol
EVH on NYSE
Location
1812 North Moore St, Suite 1705, Arlington, VA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 96.3 % -6.82%
Debt-to-equity 142 % +10.3%
Return On Assets -5.14 % -80.5%
Operating Margin -3.63 % -1448%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 118M shares +1.05%
Entity Public Float 2.2B USD -35.3%
Common Stock, Value, Issued 1.18M USD +1.03%
Weighted Average Number of Shares Outstanding, Basic 116M shares +1.04%
Weighted Average Number of Shares Outstanding, Diluted 116M shares +1.04%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.96B USD +45.3%
Revenue from Contract with Customer, Excluding Assessed Tax 2.2B USD -6.71%
Cost of Revenue 1.84B USD -4.18%
Costs and Expenses 2.23B USD -6.89%
Operating Income (Loss) -37.7M USD +16.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -132M USD -39.5%
Income Tax Expense (Benefit) -1.1M USD +94.5%
Net Income (Loss) Attributable to Parent -130M USD -75.3%
Earnings Per Share, Basic -1 USD/shares -71.3%
Earnings Per Share, Diluted -1 USD/shares -71.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 151M USD +49.1%
Accounts Receivable, after Allowance for Credit Loss, Current 359M USD -4.01%
Assets, Current 562M USD +7.93%
Property, Plant and Equipment, Net 77.3M USD +2.62%
Operating Lease, Right-of-Use Asset 5.34M USD -46.1%
Intangible Assets, Net (Excluding Goodwill) 651M USD -8.45%
Goodwill 1.14B USD +1.86%
Assets 2.46B USD -0.55%
Accounts Payable, Current 69.5M USD +78%
Employee-related Liabilities, Current 38.3M USD +22.2%
Accrued Liabilities, Current 63.9M USD -24.7%
Contract with Customer, Liability, Current 2.33M USD -48.8%
Liabilities, Current 558M USD +15.3%
Contract with Customer, Liability, Noncurrent 330K USD -43.7%
Deferred Income Tax Liabilities, Net 10.5M USD -16.8%
Operating Lease, Liability, Noncurrent 8.41M USD -72.7%
Other Liabilities, Noncurrent 3.79M USD +10.4%
Liabilities 1.34B USD +8.06%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.71M USD -26%
Retained Earnings (Accumulated Deficit) -865M USD -17.8%
Stockholders' Equity Attributable to Parent 896M USD -15%
Liabilities and Equity 2.46B USD -0.55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.57M USD -7.01%
Net Cash Provided by (Used in) Financing Activities 108M USD +625%
Net Cash Provided by (Used in) Investing Activities -13.1M USD -34.5%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 117M shares +1.04%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 99.3M USD +891%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 178M USD +29%
Deferred Tax Assets, Valuation Allowance 47.8M USD +49.5%
Deferred Tax Assets, Gross 194M USD -2.56%
Operating Lease, Liability 32.6M USD -11.7%
Depreciation 28.6M USD -9.21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -186M USD -74.3%
Lessee, Operating Lease, Liability, to be Paid 34.6M USD -23.4%
Property, Plant and Equipment, Gross 271M USD +12.3%
Operating Lease, Liability, Current 24.2M USD +295%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.03M USD -59.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 16.6M USD +99.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +27.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2M USD -75.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.79M USD -74.1%
Deferred Tax Assets, Operating Loss Carryforwards 125M USD +1.71%
Unrecognized Tax Benefits 2.5M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.37M USD -76.4%
Operating Lease, Payments 3.53M USD -7.89%
Additional Paid in Capital 1.78B USD -1.5%
Amortization of Intangible Assets 77.7M USD -13.6%
Depreciation, Depletion and Amortization 24.1M USD -18.5%
Deferred Tax Assets, Net of Valuation Allowance 146M USD -12.6%
Share-based Payment Arrangement, Expense 31M USD -40.8%
Interest Expense 47.3M USD +80.4%